Target intelligence / Profile preview

Ion channel protein (Null)

Target
Null
Molecular classification
Ion channel, Voltage-gated ion channel, Ligand-gated ion channel, Mechanosensitive ion channel, Cyclic nucleotide-gated ion channel, Calcium-gated ion channel, Chloride channel, Potassium channel, Sodium channel
01

Overview

Ion channel proteins are transmembrane proteins that create aqueous pores allowing selective movement of ions such as sodium (Na\(^+\)), potassium (K\(^+\)), calcium (Ca\(^{2+}\)), chloride (Cl\(^{-}\)), and protons (H\(^{+}\)) across biological membranes[1][5][7]. They are classified by the ion they conduct (e.g., sodium, potassium, calcium, chloride), their gating mechanism (voltage-gated, ligand-gated, mechanosensitive), subcellular localization (plasma membrane, endoplasmic reticulum, mitochondria), and sequence/protein structure[1][3][5][9][10]. Ion channels play essential roles in cell excitability, homeostasis, and intercellular communication, and defects in channel function underpin a wide range of human diseases called channelopathies[7]. Ion channel modulation is a key strategy for numerous drugs, though specificity and safety are challenges due to widespread functional importance and potential for systemic effects[7].

Other names
Ion channelschannel proteinsionotropic receptors
02

Mechanism of action

Channel blocking (inhibition); Channel opening (activation/potentiation); Modulation of gating mechanisms (voltage, ligand, mechanical); Allosteric modulation

03

Biological functions

Electrical signal transductionMaintenance of membrane potentialRegulation of cell volumeMuscle contractionNeurotransmitter releaseSensory perceptionCell proliferationApoptosisImmune response
04

Disease associations

Channelopathies (inherited disorders caused by channel mutations)EpilepsyCardiac arrhythmias (e.g., long QT syndrome)Cystic fibrosisNeuropathic painHypertensionMigraineNeurodegenerative diseases
05

Safety considerations

Proarrhythmic effects for some channel blockers (cardiac risk)CNS toxicity (e.g., seizures with sodium channel inhibitors)Electrolyte disturbancesOff-target effects due to broad distribution
06

Interacting drugs

Lidocaine (blocks voltage-gated sodium channels)

5 more in the full profile.

07

Biomarkers

SCN5A mutation (channelopathy in Brugada syndrome)CFTR gene mutation (cystic fibrosis diagnosis)KCNQ1 or KCNH2 mutations (long QT syndrome)CACNA1C (calcium channel disorders)

Beyond the preview

Go deeper on Ion channel protein (Null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ion channel protein (Null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call